Argent Biopharma Ltd
H5O0
Company Profile
Business description
Argent Biopharma Ltd is a drug discovery company that addresses unmet medical needs. The company focuses on multidisciplinary methods with nanotechnology, developing multi-target therapies for comprehensive disease management, especially in the central nervous system and immunology treatments. The products of the company include CannEpil for refractory epilepsy and cerebral palsy, CimetrA for acute lung injury, and ARDS, and CogniCann for enhancing the quality of life in dementia and Alzheimer's patients, with additional treatments in development, and others.
Contact
295 Rokeby Road
Suite 1
SubiacoWA6008
AUST: +61 865552950
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
30 June 2026
Employees
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,826.70 | 48.80 | 0.56% |
| CAC 40 | 7,900.03 | 21.57 | 0.27% |
| DAX 40 | 24,465.96 | 83.60 | -0.34% |
| Dow JONES (US) | 44,714.68 | 256.38 | 0.58% |
| FTSE 100 | 8,975.60 | 108.58 | 1.22% |
| HKSE | 24,028.37 | 136.05 | 0.57% |
| NASDAQ | 20,579.80 | 31.53 | -0.15% |
| Nikkei 225 | 39,646.36 | 174.92 | -0.44% |
| NZX 50 Index | 12,760.20 | 8.41 | -0.07% |
| S&P 500 | 6,274.47 | 11.21 | 0.18% |
| S&P/ASX 200 | 8,589.20 | 50.60 | 0.59% |
| SSE Composite Index | 3,509.68 | 16.63 | 0.48% |